Todisco Joseph 4
4 · CorMedix Inc. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Todisco Joseph
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-04-01−59,170→ 440,830 totalExercise: $3.38Exp: 2032-05-09→ Common Stock (59,170 underlying) - Exercise/Conversion
Common Stock
2025-04-01$3.38/sh+59,170$199,995→ 530,721 total
Footnotes (2)
- [F1]The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.
- [F2]These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.